[Effect and safety of transrectal 137 CS gamma-rays in the treatment of benign prostatic hyperplasia].
OBJECTIVE
To evaluate the effect and safety of transrectal 137Cs gamma-ray therapy for benign prostatic hyperplasia.


METHODS
Thirty cases of BPH were treated by transrectal 137Cs gamma-rays.


RESULTS
After 6 months there was significant improvement in the maximum urine flow, IPSS and QOL (P < 0.05). But no significant changes were observed in the prostate volume and residual urine (P > 0.05).


CONCLUSIONS
Transrectal 137Cs gamma-ray therapy is safe and effective in the treatment of BPH.
Li
Xin
X
Department of Urology, the First Hospital of Peking University, Institute of Urology, Peking University, Beijing 100034, China.
Li
Ning-chen
NC
Wang
Gang
G
Na
Yan-qun
YQ
D000368:Aged; D000369:Aged, 80 and over; D002588:Cesium Radioisotopes / Q000627:therapeutic use*; D005720:Gamma Rays / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000532:radiotherapy*; D011788:Quality of Life; D014563:Urodynamics
D002588:Cesium Radioisotopes